期刊文献+

结合珠蛋白基因1/2多态性与中国人冠心病易感性的关联研究 被引量:5

Association of haptoglobin 1/2 polymorphism with coronary heart disease in Chinese
原文传递
导出
摘要 目的通过分析冠心病患者及冠脉正常组中结合珠蛋白(haptoglobin,HP)基因1/2多态性分布,初步探讨HP基因1/2多态性与冠心病易感性的关系。方法经冠脉造影确诊冠心病组189例,冠脉正常对照组242名;采用聚合酶链反应-限制性片段长度多态性技术检测所有受试者HP基因型。结果冠心病组HP基因型分布与对照组相比差异有统计学意义(P=0.002),表现为HP2-2基因型在冠心病组的频率明显高于对照组(0.54 vs.0.35,P=0.000),单因素分析显著增加冠心病的风险(OR=2.166,95%CI:1.467~3.196),HP2等位基因的频率也明显高于对照组(0.74 vs.0.61)。同时,多因素Logistic回归分析表明HP2-2基因型是冠心病的独立危险因素(P=0.002;OR-2.101,95%CI:1.311~3.367)。结论HP2-2基因型与冠心病的发生相关,可能是冠心病发病的独立危险因子;HP2等位基因可能是中国人冠心病的易感基因。 Objective To assess the association of haptoglobin (HP)1/2 polymorphism with coronary heart disease (CHD) in Chinese Hans. Methods One hundred and eighty-nine CHD patients and 242 healthy controls confirmed with angiography were recruited. Polymerase chain reactiowrestriction fragment length polymorphism (PCR-RFLP) method was utilized to genotype the HP1 and HP2 alleles and genotype frequencies in cases and controls were compared. Results The frequency of HP2-2 genotype was significantly higher in CHDs than in controls (0.54 vs. 0.35, P=0. 000). The HP2-2 genotype significantly increased the risk for CHD in univariable analysis (OR = 2. 166, 95% CI: 1. 467-3. 196). Multifactor Logistic regression analysis indicated that HP2-2 genotype is an independent risk factor to CHD (P= 0. 002; OR= 2. 101, 95% CI: 1. 311-3. 367). Similarly, the HP2 allele frequency in the CHD group was significantly higher than that in the control subjects (0.74 vs. 0. 61, P=0. 000). Conclusion The HP2-2 genotype is associated with CHD in Chinese. HP2-2 genotype may be an independent risk factor to CHD, and HP2 allele may be a genetic susceptibility factor to CHD in Chinese.
出处 《中华医学遗传学杂志》 CAS CSCD 北大核心 2011年第1期60-63,共4页 Chinese Journal of Medical Genetics
基金 浙江省自然科学基金(Y206531)
关键词 结合珠蛋白基因 多态性 冠状动脉硬化性心脏病 haptoglobin gene polymorphism coronary heart disease
  • 相关文献

参考文献19

  • 1段成城,徐力辛,陈倩.囊泡相关膜蛋白8基因多态性与冠状动脉粥样硬化性心脏病的相关性研究[J].中华医学遗传学杂志,2010,27(3):329-332. 被引量:6
  • 2程广辉,王慧,马龙,张凯,黎莉,龚瑶琴,刘奇迹.OX40基因rs2298212位点与汉族人群冠状动脉粥样硬化疾病的关联研究[J].中华医学遗传学杂志,2010,27(2):171-175. 被引量:4
  • 3Langlois MR, Delanghe JR. Biological and clinical significance of haptoglobin polymorphism in hum Clin Chem, 1996, 42: 1589- 1600.
  • 4Asleh R, Marsh S, Shilkrut M, et al. Genetically determined heterogeneity in hemoglobin scavenging and susceptibility to diabetic cardiovascular disease. Circ Res, 2003,92 :1193- 1200.
  • 5Erickson LM, Kim HS, Maeda N. Junction between genes in the haptoglobin gene cluster of primates. Genomics, 1992, 14: 948-958.
  • 6Loftus BJ, Kim UJ, Sneddon VP, et al. Genome duplications and other features in 12 Mb of DNA sequence from human chromosome 16p and 16q. Genomics, 1999, 60;295-308.
  • 7Koch W, Latz W, Eichinger M, et al. Genotyping of the common haptoglobin Hp 1/2 polymorphsm based on PCR. Clin Chem, 2002, 48:1377-1382.
  • 8Scheil HG, Scheffrahn W. Haptoglobin (HPA)-subtypes in Swiss populations. Anthrop Anz, 1998,56:25-30.
  • 9Pernod G, Bosson JL, Golshayan D, et al. The diamant Alpin Dialysis cohort study:clinico-biological characteristics and cardiovascular genetic risk profile of incident patients. J Nephro, 2004, 17:66- 75.
  • 10Levy AP, Hochberg I, Jablonski K, et al. Haptoglobin phenotype is an independent risk factor for cardiovascular disease in individuals with diabetes: the strong heart study. J Am Coll Cardiol, 2002, 40:1984 -1990.

二级参考文献36

  • 1Libby P, Ridker PM, Maseri A. Inflammation and atherosclerosis. Circulation, 2002, 105: 1135-1143.
  • 2Schonbeck U, Libby P. CD40 signaling and plaque instability. Circ Res,2001, 89: 1092-1103.
  • 3Ria M, Eriksson P, Boquist S, et al. Human genetic evidence that OX40 is implicated in myocardial infarction. Biochem Biophys Res Commun, 2006,339: 1001-1006.
  • 4Wang X, Ria M, Kelmenson PM, et al. Positional identification of TNFSF4, encoding OX40 ligand, as a gene that influences atherosclerosis susceptibility. Nat Genet, 2005,37: 365-372.
  • 5Mendel I, Shevach EM. Activated T cells express the OX40 ligand: requirements for induction and costimulatory function. Immunology,2006,117: 196-204.
  • 6lmura A, Hori T, Imada K, et al. The human OX40/gp34 system directly mediates adhesion of activated T cells to vascular endothelia cells. J Exp Med, 1996, 183:2185-2195.
  • 7Pogers PR, Song J, Gramnglial, et al. OX40 promotes Bcl-xL and Bcl 2 expression and is essential for long-term survival of CD4 Tcells. Immunity, 2001, 15:445-455.
  • 8van Wanrooij EJ, van Puijvelde GH, de Vos P, et al. Interruption of the Tnfrsf4/Tnfsf4 (OX40/OX40L) pathway attenuates atherogenesis in low density lipoprotein recepterdeficient mice. Arterioscler Theromb Vasc Biol, 2007,27:204- 210.
  • 9Chen YY, Rollins J, Paigen B, et al. Toward understanding the molecular basis of atherosclerosis with genetics and genomics. Cell Metabo 2007, 6: 164-179.
  • 10Naruko T, Ueda M, Ha K, et al. Neutrophil infilration of culprit lesions in acute coronary syndromes. Circulation, 2002, 106: 2894-2900.

共引文献8

同被引文献57

  • 1Langlois MR, Delanghe JR. Biological and clinical significance of haptoglobin polymorphism in humans [ J ]. Clin Chem, 1996,42 (10) :1589-1600.
  • 2Brunetti ND, Correale M, Pellegrino PL, et al. Acute phase pro- teins in patients with acute coronary syndrome: correlations with diagnosis, clinical features, and angiographic findings[ J]. Eur J Intern Med,2007,18 ( 2 ) : 109-117.
  • 3Asleh R, Marsh S, Shilkrut M, et al. Genetically determined heterogeneity in hemoglobin scavenging and susceptibility to diabetic cardiovascular disease [ J ]. Circ Res,2003,92 ( 11 ) :1193-1200.
  • 4Erickson LM, Kim His, Maeda N. Junction between genes in the haptoglobin gene cluster of primates [ J ]. Genomics, 1992,14 ( 4 ) : 948-958.
  • 5Loftus B J, Kim U J, Sneddon VP, et al. Genome duplications and other features in 12 MB of DNA sequence of human chromosome 16 p and 16 q[ J]. Genomics, 1999,60(3) :295-308.
  • 6Koch W, Latz W, Eichinger M, et al. Genotyping of the common haptoglobin Hp 1/2 polymorphsm based onPCR[ J]. Clin Chem, 2002,48 ( 9 ) : 1377-1382.
  • 7Scheil HG, Scheffrahn W. Haptoglobin (HPA)-subtypen in schweizerischen populationen[ J]. Anthrop Anz,1998,56(1) :25-30.
  • 8Pernod G, Bosson JL, Golshayan D, et al. The Diamant Dialysis cohort study: elinico-biologieal characteristics and cardiovascular genetic risk profile of incident patients [ J ]. J nephrol, 2004,17 ( 1 ) :66-75.
  • 9Lavie L, Lotan R, Hochberg I, et al. Haptoglobin phenotype is a risk factor for cardiovascular disease in patients with obstructive sleep apnea syndrome[ J]. Sleep,2003,26(5 ) :592-595.
  • 10Levy AP, Hochberg I, Jablonski K, et al. Haptoglobin phenotype is an independent risk factor for cardiovascular disease in individuals with diabetes : the strong heart study [ J ]. J Am Coil Cardiol, 2002,40( 11 ) :1984-1990.

引证文献5

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部